NDC Package 64679-153-04 Valacyclovir Hydrochloride

View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

64679-153-04

Package Description:

500 TABLET, FILM COATED in 1 BOTTLE

Product Code:

64679-153

Proprietary Name:

Valacyclovir Hydrochloride

Usage Information:

Cold Sores (Herpes Labialis): Valacyclovir tablets, USP are indicated for treatment of cold sores (herpes labialis). The efficacy of valacyclovir tablets, USP initiated after the development of clinical signs of a cold sore (e.g., papule, vesicle, or ulcer) has not been established.Genital Herpes: Initial Episode: Valacyclovir tablets, USP are indicated for treatment of the initial episode of genital herpes in immunocompetent adults. The efficacy of treatment with valacyclovir tablets, USP when initiated more than 72 hours after the onset of signs and symptoms has not been established.Recurrent Episodes: Valacyclovir tablets, USP are indicated for treatment of recurrent episodes of genital herpes in immunocompetent adults. The efficacy of treatment with valacyclovir tablets, USP when initiated more than 24 hours after the onset of signs and symptoms has not been established.Suppressive Therapy: Valacyclovir tablets, USP are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in immunocompetent and in HIV-infected adults. The efficacy and safety of valacyclovir tablets, USP for the suppression of genital herpes beyond 1 year in immunocompetent patients and beyond 6 months in HIV-infected patients have not been established.Reduction of Transmission: Valacyclovir tablets, USP are indicated for the reduction of transmission of genital herpes in immunocompetent adults. The efficacy of valacyclovir tablets, USP for the reduction of transmission of genital herpes beyond 8 months in discordant couples has not been established. The efficacy of valacyclovir tablets, USP for the reduction of transmission of genital herpes in individuals with multiple partners and non-heterosexual couples has not been established. Safer sex practices should be used with suppressive therapy (see current Centers for Disease Control and Prevention [CDC] Sexually Transmitted Diseases Treatment Guidelines).Herpes Zoster: Valacyclovir tablets, USP are indicated for the treatment of herpes zoster (shingles) in immunocompetent adults. The efficacy of valacyclovir tablets, USP when initiated more than 72 hours after the onset of rash and the efficacy and safety of valacyclovir tablets, USP for treatment of disseminated herpes zoster have not been established.

11-Digit NDC Billing Format:

64679015304

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

500 EA

NDC to RxNorm Crosswalk:

RxCUI: 313564 - valACYclovir 1 GM Oral Tablet

RxCUI: 313564 - valacyclovir 1000 MG Oral Tablet

RxCUI: 313564 - valacyclovir (as valacyclovir HCl) 1 GM Oral Tablet

RxCUI: 313564 - valacyclovir 1 GM Oral Tablet

RxCUI: 313565 - valACYclovir 500 MG Oral Tablet

Labeler Name:

Wockhardt Usa Llc.

Sample Package:

Start Marketing Date:

05-24-2010

Listing Expiration Date:

12-31-2022

Exclude Flag:

Code Structure:

64679 - Wockhardt Usa Llc.
- 64679-153 - Valacyclovir Hydrochloride
  - 64679-153-04 - 500 TABLET, FILM COATED in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
64679-153-01	21 TABLET, FILM COATED in 1 BOTTLE
64679-153-02	30 TABLET, FILM COATED in 1 BOTTLE
64679-153-03	90 TABLET, FILM COATED in 1 BOTTLE
64679-153-05	10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK
64679-153-06	250 TABLET, FILM COATED in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 64679-153-04?

The NDC Packaged Code 64679-153-04 is assigned to a package of 500 tablet, film coated in 1 bottle of Valacyclovir Hydrochloride, labeled by Wockhardt Usa Llc.. The product's dosage form is and is administered via form.

Is NDC 64679-153 included in the NDC Directory?

No, Valacyclovir Hydrochloride with product code 64679-153 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Wockhardt Usa Llc. on May 24, 2010 and its listing in the NDC Directory is set to expire on December 31, 2022 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 64679-153-04?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 500.

What is the 11-digit format for NDC 64679-153-04?

The 11-digit format is 64679015304. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	64679-153-04	5-4-2	64679-0153-04

Table of Contents